Tag: NJY UNE USA NAM

Modern Meadow Enters Development Partnership with Mercedes-Benz: Leather Alternative for CONCEPT AMG GT XX Technology Program

The use of Mercedes-Benz's LABFIBER Biotech Leather Alternative in the CONCEPT AMG GT XX is a first in the automotive sector and its creation is...

Sun Pharma Announces Appointment of Richard Ascroft as CEO North America

PRINCETON, N.J., June 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes...

JPMA is now the Baby Safety Alliance

Organization will continue to champion safer products for babies and peace of mind for parents MT. LAUREL, N.J., June 24, 2025 /PRNewswire/ -- The Juvenile Products Manufacturers...

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

TOMS RIVER, N.J., June 20, 2025 /PRNewswire/ -- In a supplement market saturated with empty promises and low-quality formulations, Pals Health emerges as a brand committed to...

PRIORITIZE PROSTATE SCREENING–IT’S THE BEST DEFENSE AGAINST PROSTATE CANCER, SAYS PROCURE

SOMERSET, N.J., June 23, 2025 /PRNewswire/ -- ProCure Proton Therapy Center reminds area residents about the critical importance to men of prostate-specific antigen (PSA)...

Savvas Offers K-12 Educators Free Access to Robust Science of Reading Resources

On-demand webinars presented by leading literacy experts now available on the Savvas Science of Reading Digital Bookshelf, just in time for summer learning PARAMUS, N.J.,...

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing

Collaboration of over one month has ended based on Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing...

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

Both subcutaneous and oral formulations will advance straight to phase 3 development based on completed clinical studies and feedback received from regulatory authorities1,2PLAINSBORO, N.J.,...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsNJY UNE USA NAM

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your...

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock

SEEM Board Meeting and Annual Meeting of Participants and Stakeholders Scheduled on June 24

Tag: NJY UNE USA NAM

Modern Meadow Enters Development Partnership with Mercedes-Benz: Leather Alternative for CONCEPT AMG GT XX Technology Program

Sun Pharma Announces Appointment of Richard Ascroft as CEO North America

JPMA is now the Baby Safety Alliance

Pals Health Redefines Supplement Standards with Clinically Proven Ingredients and Exceptional Bioavailability

PRIORITIZE PROSTATE SCREENING–IT’S THE BEST DEFENSE AGAINST PROSTATE CANCER, SAYS PROCURE

Savvas Offers K-12 Educators Free Access to Robust Science of Reading Resources

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Novo Nordisk advances early-stage obesity medication, amycretin, to phase 3 clinical development based on early-phase clinical trial results in people with obesity or excess...

PARKE BANCORP, INC. ANNOUNCES CASH DIVIDEND

With the Potential for Extreme Heat, PSE&G Is Prepared and Urges Customers to Stay Safe and Energy Smart

SUBARU RELEASES SEVENTH ANNUAL CORPORATE IMPACT REPORT

New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us